【摘 要】
：
Purpose: To improve tumor targeting ability and anti-glioblastoma efficacy, a cyclic-RGD decorated polymeric micelle carrying stapled PMI was designed for the first time to target tumors, activate p53
【机 构】
：
Key Laboratory of Smart Drug Delivery of the Ministry of Education,Fudan University School of Pharma
【出 处】
：
2014年中国药物制剂大会——中国药学会药剂专业委员会年会、第六届亚洲阿登制药技术研讨会暨国际控释协会中国分会年会
论文部分内容阅读
Purpose: To improve tumor targeting ability and anti-glioblastoma efficacy, a cyclic-RGD decorated polymeric micelle carrying stapled PMI was designed for the first time to target tumors, activate p53 pathway and sensitize glioblastoma to temozolomide in vitro and in vivo.
其他文献
Gene transfer vector is one of the key technologies of gene therapy technique.Gene carriers generally can be divided into two major categories of virus and non-virus, the former is subjected to securi
In this work, two bubble-generating agents, ammonium bicarbonate (ABC) and sodium bicarbonate (SBC) that can generate CO2 bubbles, are separately encapsulated in carrier systems for actively triggerin
This presentation discusses the important role of bioequivalence (BE) study in drug product development, the adjusting of BE evaluation strategy of CDE in recent years, and common defects in BE studie
Today eight out of every ten prescriptions (~80%) in the US are filled with generic products.Uninterrupted supply of high quality medication is in the best interest of the industry as well as our pati
Developing pediatric drug products with poorly water soluble drugs is a challenging task.Enabling oral delivery technologies are required to improve both the rate and extent of absorption of these poo
随着新医改的推进,各地各级医疗机构正在逐步实施药品零差价,这为医院制剂的发展带来了新的机遇;与此同时,国家对于医疗机构制剂研制及质量标准的要求不断提高,也为医院制剂带来了新的挑战.在这一新形势下,我们应当紧跟国家、军队医疗机构制剂的政策导向;加强与高校、科研院所的合作;采用先进的制剂技术,改善、提高现有制剂的处方、工艺及质量标准;开发药物新剂型;针对疑难杂症开发特色中药制剂,开展特色医疗,满足临床
In the past several years, gene therapy has received significant attention due to its potential application in the replacement of dysfunctional genes and treatment of acquired diseases.However, naked
Aim: To develop a theranostic nanoemulsion (TNE) that can co-deliver the conjugates of a hydrophobic drug paclitaxel (PTX) and a hydrophilic imaging probe sulforhodamine B (SRB).Materials & methods: T
RNA interference (RNAi) is emerging as one of promising strategies for tumor therapy, especially for inhibiting tumor metastasis.However, an efficient and safety non-virus delivery system for clinical
The development of effective therapies for central nervous system (CNS) disorders remains a critical challenge for the pharmaceutical industry.One of the most important obstacles for drug brain delive